INS and Alzheimer disease: In recent years, Alzheimer’s disease (AD) has been considered as a metabolic disease mediated by alterations in brain insulin responsiveness, glucose utilization, and energy metabolism that can lead to increased oxidative stress, inflammation, and worsening insulin resistance (252).